What should the optimal timing be for amifostine administration relative to radiation and chemotherapy?
Komaki
Ritsuko
R
D004999:Amifostine / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000532:radiotherapy*; D003131:Combined Modality Therapy; D004334:Drug Administration Schedule; D023381:Endpoint Determination; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D011837:Radiation-Protective Agents / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D015203:Reproducibility of Results; D012107:Research Design
D011837:Radiation-Protective Agents; D004999:Amifostine